| COMPANY |
Centene Corporation |
| COURT |
United States District Court for the Southern District of New York |
| CASE NUMBER |
1:25-cv-05659 |
| JUDGE |
The Hon. Andrew Lamar Carter Jr. |
| CLASS PERIOD |
December 12, 2024, through June 30, 2025 |
| SECURITY TYPE |
Securities |
LEAD PLAINTIFF DEADLINE IS SEPTEMBER 8, 2025.
If you have suffered losses and would like to discuss your rights, please fill out this form or you may contact Jonathan Naji, Esq. at (484) 270-1453 or via e-mail at info@ktmc.com.
Case Background:
A class action lawsuit was filed on behalf of those who purchased or otherwise acquired Centene Corporation (“Centene”) (NYSE: CNC) securities between December 12, 2024, and June 30, 2025, inclusive (the “Class Period”).
The Class Period begins on December 12, 2024, when Centene issued a press release announcing its 2025 guidance. Specifically, Centene highlighted that the company has “improved our core operations and invested in the experience of our customers and providers, all while delivering on our financial commitments,” and that Centene is “reiterating our 2024 adjusted diluted EPS guidance of greater than $6.80. Additionally, we issued 2025 adjusted diluted EPS guidance of greater than $7.25, representing more than 6% year-over-year growth.” That same day, Centene hosted an analyst and investor day, wherein Centene touted that “Stability in earnings power in the face of unprecedented headwinds provide Centene with a solid jump off point for 2025 and beyond. As you've likely seen by now, we've issued 2025 adjusted EPS guidance of greater than $7.25, representing more than 6% year-over-year growth compared to this year's current outlook.” Centene also noted that the company expected “7.6% growth at the midpoints, $11 billion of additional premium revenue compared to 2024 for a 2025 guidance midpoint of $155 billion of premium and service revenue.”
On July 1, 2025, Centene announced it was withdrawing the company’s previous 2025 GAAP and adjusted diluted EPS guidance of $7.25 per share and issued a reduced guidance of approximately $1.8 billion, which corresponds to an adjusted diluted EPS impact of approximately $2.75. Centene attributed the lowered guidance to “the Company’s membership estimates and morbidity trend estimates for both its members and the aggregate market, calculated by state.” On this news, the price of Centene common stock declined $22.87 per share, or approximately 40.4%, from a close of $56.65 per share on July 1, 2025, to close at $33.78 per share on July 2, 2025.
The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material facts about the company’s business, operations, and prospects. Specifically, Defendants misrepresented and/or failed to disclose that: (1) Centene’s marketplace share showed lower-than-anticipated enrollment and increased aggregate market morbidity; and (2) as a result, Defendants’ statements about the company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
What is a Lead Plaintiff?
A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Filling out the online form above or communicating with any counsel is not necessary to participate or share in any recovery achieved in this case. Any member of the purported class may move the court to serve as a lead plaintiff through counsel of his/her choice, or may choose to do nothing and remain an inactive class member.